How to buy DrReddys Laboratories shares in India | 07 March

Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

DrReddys Laboratories share price in India and how to buy DrReddys Laboratories stock

Own DrReddys Laboratories share in just a few minutes.

Updated

Fact checked

Dr. Reddy's Laboratories Limited is a drug manufacturers-specialty & generic business based in the US. DrReddys Laboratories shares (RDY) are listed on the NYSE and all prices are listed in US Dollars. DrReddys Laboratories employs 21,650 staff and has a market cap (total outstanding shares value) of USD$10.1 billion.

How to buy shares in DrReddys Laboratories from India

  1. Compare share trading platforms. If you're a beginner, look for a platform with low commissions, expert ratings and investment tools to track your portfolio. Narrow down top brands with our comparison table.
  2. Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and bank information. Fund your account with a bank transfer, credit card or debit card.
  3. Search for DrReddys Laboratories Find the stock by name or ticker symbol: RDY. Research its history to confirm it's a solid investment against your financial goals.
  4. Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until DrReddys Laboratories reaches your desired price. To spread out your purchase, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
  5. Decide on how many to buy. Weigh your budget against a diversified portfolio that can minimize risk through the market's ups and downs. You may be able to buy a fractional share of DrReddys Laboratories, depending on your broker.
  6. Check in on your investment. Congratulations, you own a part of DrReddys Laboratories. Optimize your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.

Compare online brokers

Data updated regularly
Name Product Number of stocks CFDs Shares Available Markets Link
5paisa
All NSE/BSE listed stocks
No
Yes
IN
Go to site
More info
Tradesmart
All NSE/BSE listed stocks
No
Yes
IN
Go to site
More info
Saxo Bank
19,000+
Yes
Yes
AU, CN,CZ, DK, ES, FR, TW, HK, IT, HU, SA, NE, NO, PL, RU, SG, CH, UK, JP
Go to site
CFD service. Your capital is at risk.
More info
CFD Service. Your capital is at risk.
Sharekhan
All NSE/BSE listed stocks
No
Yes
Available in 72 countries
More info
Upstox
All NSE/BSE listed stocks
No
Yes
IN
More info
Motilal Oswal
100+
No
Yes
IN, US
More info
Religare
All NSE/BSE listed stocks
No
Yes
IN
More info
ICICI Direct
All NSE/BSE listed stocks
No
Yes
India and rest of the world.
More info
Bajaj Finserv Securities
All NSE/BSE listed stocks
No
Yes
IN
More info
loading

Compare up to 4 providers

DrReddys Laboratories share price

Use our graph to track the performance of RDY stocks over time.

DrReddys Laboratories shares at a glance

Information last updated 2021-03-03.
52-week rangeUSD$33.1177 - USD$73.39
50-day moving average USD$65.1053
200-day moving average USD$65.9104
Wall St. target priceUSD$72.5
PE ratio 43.4473
Dividend yield USD$0.292 (0.48%)
Earnings per share (TTM) USD$1.404
Promoted
5paisa

Invest your money now with 5paisa

  • No minimum account balances
  • Relatively low commissions per trade
  • Attractive customisation features

Is it a good time to buy DrReddys Laboratories stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

DrReddys Laboratories price performance over time

Historical closes compared with the last close of $N/A

1 week (2021-02-24) N/A
1 month (2021-02-03) N/A
3 months (2020-12-03) N/A
6 months (2020-09-03) N/A
1 year (2020-03-03) N/A
2 years (2019-03-03) N/A
3 years (2018-03-03) N/A
5 years (2016-03-03) N/A

Is DrReddys Laboratories under- or over-valued?

Valuing DrReddys Laboratories stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of DrReddys Laboratories's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

DrReddys Laboratories's P/E ratio

DrReddys Laboratories's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 43x. In other words, DrReddys Laboratories shares trade at around 43x recent earnings.

That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.

DrReddys Laboratories's PEG ratio

DrReddys Laboratories's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 3.0915. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.

The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into DrReddys Laboratories's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.

DrReddys Laboratories financials

Gross profit TTM USD$94 billion
Return on assets TTM 8.56%
Return on equity TTM 13.37%
Profit margin 11.38%
Book value $11.575
Market capitalisation USD$10.1 billion

TTM: trailing 12 months

Shorting DrReddys Laboratories shares

There are currently 1.2 million DrReddys Laboratories shares held short by investors – that's known as DrReddys Laboratories's "short interest". This figure is 4.4% up from 1.1 million last month.

There are a few different ways that this level of interest in shorting DrReddys Laboratories shares can be evaluated.

DrReddys Laboratories's "short interest ratio" (SIR)

DrReddys Laboratories's "short interest ratio" (SIR) is the quantity of DrReddys Laboratories shares currently shorted divided by the average quantity of DrReddys Laboratories shares traded daily (recently around 224709.14396887). DrReddys Laboratories's SIR currently stands at 5.14. In other words for every 100,000 DrReddys Laboratories shares traded daily on the market, roughly 5140 shares are currently held short.

However DrReddys Laboratories's short interest can also be evaluated against the total number of DrReddys Laboratories shares, or, against the total number of tradable DrReddys Laboratories shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case DrReddys Laboratories's short interest could be expressed as 0.01% of the outstanding shares (for every 100,000 DrReddys Laboratories shares in existence, roughly 10 shares are currently held short) or 0% of the tradable shares (for every 100,000 tradable DrReddys Laboratories shares, roughly 0 shares are currently held short).

A SIR below 10% would generally be considered to indicate a fairly optimistic outlook for the share price, with fewer people currently willing to bet against DrReddys Laboratories.

Frequently asked questions

Disclaimer: This information should not be interpreted as an endorsement of futures, stocks, ETFs, CFDs, options or any specific provider, service or offering. It should not be relied upon as investment advice or construed as providing recommendations of any kind. Futures, stocks, ETFs and options trading involves substantial risk of loss and therefore are not appropriate for all investors. Trading CFDs and forex on leverage comes with a higher risk of losing money rapidly. Past performance is not an indication of future results. Consider your own circumstances, and obtain your own advice, before making any trades.

More guides on Finder

Ask an Expert

You are about to post a question on finder.com:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy Policy and Terms.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site